Australian Prescriber An independent Review Logo

All Issues

Volume
 
  • empty

    Volume 31 Issue 5

    October 2008
  • October 2008

Time for transparency at the TGA

Time for transparency at the TGA
Editorial Agnes Vitry
  • 1 October 2008

Full transparency in pharmaceutical regulation is crucial. There are several reasons why we need access to drug regulatory information about prescription medicines.
Letters to the Editor

Compounding in community pharmacy

Romano A Fois, Andrew J McLachlan, Barry T Mewes, Iqbal Ramzan
  • 1 October 2008
Letters to the Editor

Varenicline and quitting

John Litt
  • 1 October 2008
Letters to the Editor

Therapeutic range for digoxin

John D Horowitz, Dr Ghiculescu
  • 1 October 2008
Letters to the Editor

Bronchiectasis

Rob Campagnaro
  • 1 October 2008
Letters to the Editor

Bipolar disorders

Melissa Raven, Dr Ajeet Singh, Professor Michael Berk
  • 1 October 2008
Article

How to treat hypercholesterolaemia

David Colquhoun, Greenslopes Private Hospital
  • 1 October 2008
Diagnostic tests

Current clinical applications of positron emission tomography

Aravind Ravi Kumar
  • 1 October 2008
Article

A current treatment approach for attention deficit hyperactivity disorder

Alasdair Vance
  • 1 October 2008
Sub-article

Subsidised palliative care medicines

  • 1 October 2008
Dental notes

Managing acute pain in patients with an opioid abuse or dependence disorder

Lindy J Roberts
  • 1 October 2008
Dental notes

Managing acute pain in patients with an opioid abuse or dependence disorder

Dr M McCullough
  • 1 October 2008
NEW DRUGS
Anti-thymocyte globulin
  • 1 October 2008
Galsulfase
  • 1 October 2008
Panitumumab
  • 1 October 2008

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe
Online tool
94709A0Fe3Ce0D7F C3839A5F91F1 Doctors Bag Hero